Improved survival for non-Hodgkin lymphoma patients in New South Wales, Australia

BACKGROUND: We evaluated if the survival benefit of adding rituximab to standard chemotherapy for non-Hodgkin lymphoma (NHL) observed in clinical trials has been experienced by an Australian NHL patient population. METHODS: NHL cases diagnosed in 1985-2004 in New South Wales (NSW) were followed-up t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Yu, Xue Q, Chen, Wendy H, O'Connell, Dianne L
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2010
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2886045/
https://ncbi.nlm.nih.gov/pubmed/20497580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-231
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller